Announcements Trials
Browse Landscape

Phase

Phase NA 13Phase 3 3Phase 2 2Phase 2/3 1Phase 1/2 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Breast Neoplasms 558Carcinoma, Non-Small-Cell Lung 510Prostatic Neoplasms 333Neoplasms 271Colorectal Neoplasms 271Multiple Myeloma 268Leukemia, Myeloid, Acute 225Squamous Cell Carcinoma of Head and Neck 217Lung Neoplasms 210Neoplasm Metastasis 205Carcinoma, Hepatocellular 197Melanoma 175Triple Negative Breast Neoplasms 173Pancreatic Neoplasms 171Recurrence 151Ovarian Neoplasms 151Lymphoma 142Glioblastoma 136Brain Neoplasms 133Sarcoma 129Leukemia, Lymphocytic, Chronic, B-Cell 127Carcinoma, Renal Cell 127Lymphoma, Large B-Cell, Diffuse 126Stomach Neoplasms 123Head and Neck Neoplasms 123Precursor Cell Lymphoblastic Leukemia-Lymphoma 111Rectal Neoplasms 108Myelodysplastic Syndromes 105Urinary Bladder Neoplasms 100Small Cell Lung Carcinoma 98

Interventions

Triamcinolone Acetonide 1Radiotherapy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Radiodermatitis × 1 year × Clear all
NCT05190770 2025-12-03

A Study of Oleogel-S10 Gel for the Treatment of Radiation Dermatitis in People With Breast Cancer

Memorial Sloan Kettering Cancer Center

Phase 2 Completed
18 enrolled 9 charts
Breast

Breast Neoplasms, Radiodermatitis

NCT07192588 2025-09-25

GuARD

Graegis Pharmaceuticals Ltd

Phase 2 Active not recruiting
273 enrolled
Breast

Breast Neoplasms, Radiodermatitis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡